NCT01064479 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01064479
Title	Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	M.D. Anderson Cancer Center
Indications	head and neck squamous cell carcinoma
Therapies	Erlotinib Carboplatin Docetaxel Cisplatin
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 5 of 5 entries

Facility	City	State	Zip	Country	Details
M D Anderson Cancer Center	Houston	Texas	77030	United States	Details
MD Anderson Regional Care Center-Bay Area	Nassau Bay	Texas	77058	United States	Details
MD Anderson Regional Care Center-Katy	Houston	Texas	77094	United States	Details
MD Anderson Regional Care Center-Sugar Land	Sugar Land	Texas	77478	United States	Details
MD Anderson Regional Care Center-The Woodlands	The Woodlands	Texas	77384	United States	Details

Showing 1 to 5 of 5 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01064479Clinical Trial Detail